NO129205B - - Google Patents

Download PDF

Info

Publication number
NO129205B
NO129205B NO00283/71A NO28371A NO129205B NO 129205 B NO129205 B NO 129205B NO 00283/71 A NO00283/71 A NO 00283/71A NO 28371 A NO28371 A NO 28371A NO 129205 B NO129205 B NO 129205B
Authority
NO
Norway
Prior art keywords
pyrimidine
thieno
acid
morpholino
general formula
Prior art date
Application number
NO00283/71A
Other languages
English (en)
Norwegian (no)
Inventor
E Woitun
G Ohnacker
B Narr
U Horch
R Kadatz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19702003714 external-priority patent/DE2003714C/de
Priority claimed from DE19702058086 external-priority patent/DE2058086A1/de
Priority claimed from DE19702058085 external-priority patent/DE2058085A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO129205B publication Critical patent/NO129205B/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO00283/71A 1970-01-28 1971-01-27 NO129205B (index.php)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19702003714 DE2003714C (de) 1970-01-28 2 Piperazino 4 morpholino thieno eckige Klammer auf 3,2 d eckige Klammer zu pyrimidin und dessen Saureadditions salze
DE19702058086 DE2058086A1 (de) 1970-11-26 1970-11-26 Neue 4-Morpholino-thieno[3,2-d]pyrimidine,deren Salze und Verfahren zur Herstellung
DE19702058085 DE2058085A1 (de) 1970-11-26 1970-11-26 Neues Verfahren zur Herstellung von 4-Morpholino-thieno[3,2-d]pyrimidinen

Publications (1)

Publication Number Publication Date
NO129205B true NO129205B (index.php) 1974-03-11

Family

ID=27182372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO00283/71A NO129205B (index.php) 1970-01-28 1971-01-27

Country Status (9)

Country Link
US (1) US3763156A (index.php)
AU (1) AU2468871A (index.php)
BE (1) BE762135A (index.php)
ES (2) ES387554A1 (index.php)
FR (1) FR2081464B1 (index.php)
GB (1) GB1309182A (index.php)
IL (1) IL36079A0 (index.php)
NL (1) NL7101043A (index.php)
NO (1) NO129205B (index.php)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
GB8912335D0 (en) * 1989-05-30 1989-07-12 Smithkline Beckman Intercredit Compounds
US5280026A (en) * 1989-05-30 1994-01-18 Smithkline Beecham Intercredit B.V. Thienopyrimidines
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
GB0423653D0 (en) * 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
ES2328400T3 (es) * 2005-04-21 2009-11-12 Boehringer Ingelheim International Gmbh Dihidrotienopirimidinas para el tratamiento de enfermedades inflamatorias.
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
BRPI0710874A2 (pt) 2006-04-26 2012-02-14 Hoffmann La Roche compostos de tienopirimidina, processos de produção dos referidos compostos, composições farmacêuticas contendo os mesmos, kit, produto, e usos dos compostos
CA2650295C (en) 2006-04-26 2015-12-29 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
AU2007243457B2 (en) 2006-04-26 2012-02-23 F. Hoffmann-La Roche Ag Pharmaceutical compounds
BRPI0717923A2 (pt) * 2006-12-07 2013-10-22 Genentech In '' composto, composição farmacêutica, método para tratar um câncer, processo para a produção de uma composição farmacêutica, usos, métodos para inibir ou modular a atividade da lipídeo quinase e kit ' '
TW200829594A (en) * 2006-12-07 2008-07-16 Piramed Ltd Phosphoinositide 3-kinase inhibitor compounds and methods of use
CA2704711C (en) 2007-09-24 2016-07-05 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
ATE537175T1 (de) 2007-10-19 2011-12-15 Boehringer Ingelheim Int Neue piperazino-dihydrothienopyrimidin-derivate
US8637519B2 (en) * 2007-10-19 2014-01-28 Boehringer Ingelheim International Gmbh Heterocycle-substituted piperazino-dihydrothienopyrimidines
EP2215092B1 (de) * 2007-10-19 2012-01-25 Boehringer Ingelheim International GmbH Substituierte piperidino-dihydrothienopyrimidine
JP5348725B2 (ja) * 2007-10-25 2013-11-20 ジェネンテック， インコーポレイテッド チエノピリミジン化合物の製造方法
GB0721095D0 (en) * 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
AU2010224125B2 (en) 2009-03-12 2015-05-14 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
SG175708A1 (en) 2009-05-27 2011-12-29 Genentech Inc Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
CA2772371A1 (en) * 2009-05-27 2010-12-02 F. Hoffmann-La Roche Ag Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
BR112012008483A2 (pt) * 2009-10-12 2019-09-24 Hoffmann La Roche combunações de um inibidor de pi3k e um inibidor de mex
EP2558864A1 (en) 2010-04-16 2013-02-20 Genentech, Inc. Fox03a as predictive biomarker for pi3k/akt kinase pathway inhibitor efficacy
US20140004209A1 (en) 2010-12-22 2014-01-02 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
AR094873A1 (es) 2013-02-25 2015-09-02 Genentech Inc Métodos y composiciones para detectar y tratar mutantes de akt resistentes a fármacos
US11098056B2 (en) * 2018-10-01 2021-08-24 Genzyme Corporation UDP glycosyltransferase inhibitors and methods of use
GB202014736D0 (en) * 2020-09-18 2020-11-04 Imperial College Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470356A1 (de) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
ES387553A1 (es) 1974-01-16
FR2081464B1 (index.php) 1975-04-18
ES387554A1 (es) 1974-01-16
BE762135A (fr) 1971-07-27
IL36079A0 (en) 1971-03-24
US3763156A (en) 1973-10-02
FR2081464A1 (index.php) 1971-12-03
AU2468871A (en) 1972-07-27
GB1309182A (en) 1973-03-07
NL7101043A (index.php) 1971-07-30

Similar Documents

Publication Publication Date Title
NO129205B (index.php)
JP2896532B2 (ja) 新規なピリミジン誘導体およびその製造方法
FI63587C (fi) Foerfarande foer framstaellning av anti-inflammatoriska halogenerade 4-hydroxi-2-alkyl-3-karbamoyl-2h-tieno-1,2-tiazin-1,1-dioxidderivat
CA2985547C (en) Substituted tetrahydroquinolinone compounds as ror gamma modulators
FI65435C (fi) Foerfarande foer framstaellning av immunitet raglerande och arrit motstaoende 5-(4-pyridyl)-6-(4-fluorfenyl)-2,3-dihydr oiidazo-(2,1-b)tiazol
JPH0784470B2 (ja) 活性化合物、その製法及びそれを含む医薬組成物
NO179674B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, heterosykliske N-oksidderivater av substituerte benzo[5,6Åsyklo-heptapyridiner
NO161373B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pteridin-derivater.
NO152373B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 8-fenyl-purin-derivater
CA3061209A1 (en) Compound used as autophagy regulator, and preparation method therefor and uses thereof
NO160920B (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-piperazino-pteridin-derivater.
FI61899C (fi) Foerfarande foer framstaellning av antiflogistiska och antitrombotiska 6-substituerad-3-amino-4-fenyl-1h-pyrazolo(3,4-b)pyridiner
US4224445A (en) Thienothiazine derivatives
DD216019A5 (de) Verfahren zur herstellung heterocyclisch ankondensierter pyrazolo (3,4-d) pyridin-3-one
JPH0499768A (ja) ４―（４―フェニルピリジン―２―イル）ピペラジン―１―オキシド誘導体
IL93760A (en) History of N-3] 3-Ariyl) Hydroxyamino (methylphenyl [-3-) pyridyl (- H1, H3-pyrrolo] C-1,2 [thiazole-7-carboxamide, their preparation and pharmaceutical preparations containing them
US4213984A (en) 11-(Piperazino-acetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-ones and salts thereof
JP5635592B2 (ja) ５−アルキニル−ピリジン
US3843663A (en) 1,8-naphthyridine compounds
CS207619B2 (en) Method of making the new derivatives of 5,11-dihydro-6h-pyrido 2,3-b 1,4 benzodiazepin-6-on
JPS58128384A (ja) ベンゾジオキシン化合物、その製造方法、および精神作用障害治療用医薬組成物
JPH07505394A (ja) 橋渡しビスアリールカルビノール誘導体，組成物および使用法
DK148772B (da) Analogifremgangsmaade til fremstilling af 6-(4-morpholinophenyl)-4,5-dihydro-3(2h)-pyridazinoner eller syreadditionssalte deraf
NO812431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-2-on-derivater.
JPH03106875A (ja) １―（３―ピリジルメチル）フタラジン誘導体